SCND · XBRL financial data

Scientific Industries financial statements, every quarter

The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (SCND's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue2,5862,738*2,4842,6472,7692,813*2,4072,3301,4041,627*1,2271,470
Cost of revenue1,4051,505*1,4431,3551,4061,776*1,3901,3107651,687*757848
Gross profit1,1811,233*1,0411,2921,3631,037*1,0171,020639(60)*470623
Research and development8961,194*711666683846*652677621617*704695
General and administrative8961,652*1,5221,0621,0191,220*1,251976804697*747554
Total operating expenses3,4063,574*3,1302,6292,6222,991*2,8282,5652,1612,395*2,1381,896
Other operating income (expense)————38(20)*——241450*——
Operating income (loss)(2,225)(2,341)*(2,090)(1,336)(1,259)(1,954)*(1,811)(1,545)(1,522)(2,455)*(1,668)(1,273)
Other income (expense)5(33)*(4)(2)—year only128——27(1)
Income tax expense (benefit)0(109)*0000*00—year only00
Net income (loss)(2,201)(2,223)*(2,052)(1,284)(1,180)(1,930)*(1,779)(1,523)3,994(1,913)*(1,589)(1,234)
Earnings per share, diluted USD per share(0.31)—0.20(0.12)(0.11)—0.16(0.13)0.34—(0.13)(0.10)
Weighted average shares, basic thousands of shares———————11,346———11,929
Weighted average shares, diluted thousands of shares7,004—10,43710,50410,50410,570*10,50411,34611,71311,799*11,92911,929

Balance sheet

CSV

Fiscal quarters (SCND's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents5157963525615645884708911,163955798617
Short-term investments—————————5,705—3,932
Accounts receivable1,2931,1571,1451,2151,3571,2031,207966678866535517
Inventory5,2824,8844,8685,3965,3854,0864,3544,3932,0441,4011,5671,940
Prepaid and other current assets6204144694454053535024956921,115881942
Total current assets8,57212,34111,40010,3869,6528,2887,3927,21011,88910,3898,9888,127
Property and equipment, net1,0941,0821,0501,000971885899907766691638604
Right-of-use asset1,1721,2741,1911,1101,033948935857774924844756
Goodwill115115115115115115115115115115115115
Total assets13,04816,73115,54714,27513,30711,56110,57010,22614,55712,60811,10410,107
Accounts payable1,095712767713615586973651515449406526
Accrued liabilities811778887686624790778688578417510511
Total current liabilities2,1831,8372,0501,7741,6111,7472,1331,6961,5541,3491,4451,602
Lease liability, non-current9871,008877819762694669606542595543430
Total liabilities3,1702,8452,9272,5932,3722,4412,8022,2312,0961,9451,9882,033
Accumulated deficit(25,262)(27,485)(29,537)(30,820)(32,000)(33,931)(35,709)(37,233)(33,238)(35,151)(36,740)(37,974)
Total stockholders' equity9,87813,88512,61911,68210,9359,1197,7687,92412,46210,6639,1168,074
Total liabilities and equity13,04816,73115,54714,27513,30711,56110,57010,22614,55712,60811,10410,107
Common shares outstanding (cover page) thousands of shares7,00410,50410,50410,50410,50410,50411,55411,55411,92911,92911,92911,929

Cash flows

CSV

Fiscal quarters (SCND's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(2,201)(2,223)*(2,052)(1,284)(1,180)(1,930)*(1,779)(1,523)3,994(1,913)*(1,589)(1,234)
Stock-based compensation846207*200330320316*3037373*73*116163
Net cash from operating activities(1,162)*(1,333)*(1,565)(872)*(868)*(379)*(1,331)(1,432)*——(994)(904)*
Purchases of property and equipment12*14*4825*4*23*267*10*20*68*
Net cash from investing activities1,028*(4,136)*4811,090*859*436*1,204377*864*1,387*814927*
Proceeds from issuing common stock0*6,283*7170*0*0*01,550*500*(0)*——
Net cash from financing activities13*5,738*6460*0*0*01,452*500*(0)*00*
Net change in cash(129)*281*(444)209*3*24*(118)421*232*(207)*(157)(181)*

Compare with peers

SIC 3826 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3826 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Scientific Industries6171,470(904)*11.9M5.0 quarters 10-QJun 30, 2026
Bioforce Nanosciences Holdings0.3not reported(27)*33.5M0.0 quarters 10-QJun 30, 2026
ASTROTECH8,387not reported(2,288)*2.0M5.0 quarters 10-KJun 30, 2026
Electro Sensors10,756not reported683.5M— 10-QMar 31, 2026
Radnostix1,1962,672(614)*529.2M2.0 quarters 10-QJun 30, 2026
Lifeloc Technologies9082,445(133)*2.8M6.8 quarters 10-QJun 30, 2026
Syntec Optics Holdings14,0478,274(299)*40.3M47.0 quarters 10-QJun 30, 2026
US Nuclear67352(127)62.8M0.5 quarters 10-QMar 31, 2026
Bionano Genomics3,7308,171(4,670)*11.8M2.1 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.